Gevo Quarterly Income Statements Chart
Quarterly
|
Annual
Gevo Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-06-09 | 2012-12-31 | 2011-12-31 | 2010-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| total operating revenues | 1,965,000 | 5,260,000 | 3,990,000 | 4,374,000 | 4,528,000 | 4,238,000 | 4,060,000 | ||||||||||||||||||||||||
| operating expenses: | |||||||||||||||||||||||||||||||
| cost of production | 2,544,000 | 3,423,000 | 2,587,000 | 3,155,000 | 2,480,000 | 1,931,000 | 4,425,000 | 3,456,000 | 318,000 | 2,640,000 | 3,090,000 | ||||||||||||||||||||
| depreciation and amortization | 3,494,000 | 4,277,000 | 4,451,000 | 4,684,000 | 4,994,000 | 4,754,000 | 4,575,000 | 4,458,000 | 1,250,000 | 1,088,000 | 1,091,000 | ||||||||||||||||||||
| research and development expense | 1,113,000 | 1,641,000 | 1,548,000 | 1,921,000 | 1,558,000 | 1,960,000 | 1,198,000 | 2,707,000 | 1,562,000 | 1,966,000 | 1,192,000 | 2,452,000 | 1,541,000 | 1,404,000 | 1,378,000 | 1,959,000 | 870,000 | 677,000 | 580,000 | 308,000 | 1,789,000 | 945,000 | |||||||||
| general and administrative expense | 10,761,000 | ||||||||||||||||||||||||||||||
| project development costs | 6,593,000 | 7,736,000 | 5,319,000 | 4,097,000 | 4,789,000 | 2,887,000 | 2,959,000 | ||||||||||||||||||||||||
| facility idling costs | 550,000 | 699,000 | 1,076,000 | 1,117,000 | 911,000 | 1,013,000 | 999,000 | ||||||||||||||||||||||||
| total operating expenses | 25,973,000 | 29,289,000 | 27,131,000 | 25,711,000 | 25,254,000 | 23,153,000 | 24,917,000 | 38,493,000 | 40,080,000 | 12,476,000 | 12,006,000 | 12,637,000 | 11,372,000 | 16,650,000 | 7,977,000 | 5,570,000 | 4,035,000 | 3,601,000 | 3,662,000 | 3,688,000 | 4,220,000 | 3,127,000 | |||||||||
| income from operations | -24,008,000 | -24,029,000 | -23,141,000 | -21,337,000 | -20,726,000 | -18,915,000 | -20,857,000 | -26,947,000 | -43,669,000 | -16,115,000 | -15,955,000 | -16,478,000 | -14,712,000 | -19,022,000 | -9,878,000 | -6,999,000 | -6,103,000 | -5,257,000 | -7,976,000 | -6,227,000 | -8,003,000 | -6,493,000 | |||||||||
| yoy | 15.84% | 27.04% | 10.95% | -20.82% | -52.54% | 17.38% | 30.72% | 63.53% | 196.83% | -15.28% | 61.52% | 135.43% | 141.06% | 261.84% | 23.85% | 12.40% | -23.74% | -19.04% | |||||||||||||
| qoq | -0.09% | 3.84% | 8.45% | 2.95% | 9.57% | -9.31% | -22.60% | -38.29% | 170.98% | 1.00% | -3.17% | 12.00% | -22.66% | 92.57% | 41.13% | 14.68% | 16.09% | -34.09% | 28.09% | -22.19% | 23.26% | ||||||||||
| operating margin % | |||||||||||||||||||||||||||||||
| other income | 116,000 | -3,000 | 215,000 | -1,601,000 | 305,000 | -7,000 | 711,000 | 188,000 | -279,000 | 2,878,000 | 32,000 | -437,000 | 393,000 | 91,000 | -121,000 | -532,000 | 36,000 | -13,000 | 30,000 | 4,000 | -9,000 | 20,000 | |||||||||
| interest expense | -1,107,000 | -1,113,000 | -542,000 | -546,000 | -540,000 | -536,000 | -539,000 | -451,000 | -712,000 | -2,000 | -2,000 | -173,000 | -67,000 | -6,000 | -5,000 | -535,000 | -473,000 | -541,000 | -545,000 | -605,000 | -605,000 | -767,000 | |||||||||
| interest and investment income | 3,843,000 | 4,143,000 | 4,593,000 | 5,007,000 | 5,261,000 | 5,038,000 | |||||||||||||||||||||||||
| total other income | 2,852,000 | 3,027,000 | 4,266,000 | 2,860,000 | 5,026,000 | 4,495,000 | 3,239,000 | 1,560,000 | -117,000 | 2,954,000 | 282,000 | -35,000 | 332,000 | 769,000 | -179,000 | -11,055,000 | -733,000 | -786,000 | -1,277,000 | -588,000 | -616,000 | -597,000 | |||||||||
| net income | -21,156,000 | -21,002,000 | -18,875,000 | -18,477,000 | -15,700,000 | -14,420,000 | -17,618,000 | -25,387,000 | -43,786,000 | -13,161,000 | -15,673,000 | -16,513,000 | -14,380,000 | -18,253,000 | -10,057,000 | -18,054,000 | -6,836,000 | -6,043,000 | -9,253,000 | -6,815,000 | -8,619,000 | -7,090,000 | |||||||||
| yoy | 34.75% | 45.64% | 7.13% | -27.22% | -64.14% | 9.57% | 12.41% | 53.74% | 204.49% | -27.90% | 55.84% | -8.54% | 110.36% | 202.05% | 8.69% | 164.92% | -20.69% | -14.77% | |||||||||||||
| qoq | 0.73% | 11.27% | 2.15% | 17.69% | 8.88% | -18.15% | -30.60% | -42.02% | 232.70% | -16.03% | -5.09% | 14.83% | -21.22% | 81.50% | -44.29% | 164.10% | 13.12% | -34.69% | 35.77% | -20.93% | 21.57% | ||||||||||
| net income margin % | |||||||||||||||||||||||||||||||
| net income per share | -0.09 | -0.09 | -0.08 | -0.08 | -0.07 | -0.06 | -0.07 | -0.1 | -0.19 | -0.06 | -0.08 | -0.08 | -0.07 | -0.09 | -0.05 | -0.09 | -0.09 | -0.4 | -0.64 | -0.48 | -0.66 | -0.6 | |||||||||
| weighted-average number of common shares outstanding - basic and diluted | 239,445,900 | 239,014,435 | 240,844,334 | 238,687,621 | 239,537,811 | 237,417,618 | 237,260,681 | 221,537,262 | 236,649,805 | 209,809,994 | 201,925,747 | 195,794,606 | 199,341,519 | 198,137,420 | 183,566,524 | 56,881,586 | 77,049,896 | 15,071,105 | 14,472,798 | 12,177,906 | 12,968,265 | 11,885,524 | |||||||||
| impairment loss | 24,749,000 | ||||||||||||||||||||||||||||||
| investment income | 3,067,000 | 1,839,000 | 874,000 | 78,000 | |||||||||||||||||||||||||||
| revenue and cost of goods sold | |||||||||||||||||||||||||||||||
| ethanol sales and related products | 60,000 | 71,000 | 169,000 | 34,000 | 16,000 | 5,000 | 21,000 | 83,000 | 3,700,000 | 5,931,000 | 5,554,000 | 4,966,000 | |||||||||||||||||||
| hydrocarbon revenue | 20,250 | 18,000 | 63,000 | 20,000 | 104,000 | 346,000 | 13,000 | 416,000 | 101,000 | 859,000 | 125,000 | 957,000 | 550,000 | 92,000 | |||||||||||||||||
| renewable natural gas commodity | 77,250 | 309,000 | |||||||||||||||||||||||||||||
| total revenues | 157,500 | 309,000 | 89,000 | 232,000 | 54,000 | 142,000 | 422,000 | 93,000 | 531,000 | 192,000 | 988,000 | 3,825,000 | 6,888,000 | 6,110,000 | 5,086,000 | ||||||||||||||||
| idle facility costs | 582,500 | 2,330,000 | |||||||||||||||||||||||||||||
| total cost of goods sold | 2,750,250 | 3,898,000 | 3,728,000 | 4,181,000 | |||||||||||||||||||||||||||
| gross loss | -2,592,750 | -3,589,000 | -3,639,000 | -3,949,000 | -3,841,000 | -3,340,000 | -2,372,000 | -1,901,000 | -1,429,000 | -2,068,000 | -1,656,000 | -4,314,000 | -2,539,000 | -3,783,000 | -3,366,000 | ||||||||||||||||
| operating expenses | |||||||||||||||||||||||||||||||
| selling, general and administrative expense | 7,301,250 | 11,144,000 | 9,209,000 | 9,367,000 | 7,466,000 | 9,335,000 | 4,820,000 | 3,872,000 | 3,611,000 | 3,215,000 | 2,919,000 | 2,783,000 | 3,380,000 | 2,431,000 | 2,182,000 | ||||||||||||||||
| preliminary stage project costs | 434,000 | 915,000 | 314,000 | 507,000 | 2,069,000 | 313,000 | 5,472,000 | 2,727,000 | |||||||||||||||||||||||
| other operations | 953,500 | 1,303,000 | 601,000 | 589,000 | |||||||||||||||||||||||||||
| loss on disposal of assets | 183,000 | 4,954,000 | |||||||||||||||||||||||||||||
| gain from change in fair value of derivative warrant liability | 4,000 | -1,000 | 6,000 | 43,000 | -53,000 | -31,000 | 1,000 | 7,000 | 13,000 | -2,000 | 2,000 | ||||||||||||||||||||
| gain on forgiveness of sba loan | 641,000 | ||||||||||||||||||||||||||||||
| other revenue | 22,000 | 29,000 | 70,000 | 46,000 | |||||||||||||||||||||||||||
| interest and dividend income | 252,000 | ||||||||||||||||||||||||||||||
| cost of goods sold | -583,000 | 3,482,000 | 2,794,000 | 1,994,000 | 1,960,000 | 2,260,000 | 2,644,000 | 8,139,000 | 9,427,000 | 9,893,000 | 8,452,000 | ||||||||||||||||||||
| restructuring expenses | -50,000 | 5,000 | 299,000 | ||||||||||||||||||||||||||||
| gain on forgiveness of sba loans | |||||||||||||||||||||||||||||||
| (loss) on modification of 2020 notes | -6,000 | -57,000 | -669,000 | ||||||||||||||||||||||||||||
| (loss) on conversion of 2020/21 notes to common stock | -1,373,000 | -543,000 | |||||||||||||||||||||||||||||
| gain from change in fair value of 2020/21 notes embedded derivative liability | |||||||||||||||||||||||||||||||
| grant and other revenue | 76,000 | 80,000 | 6,000 | 28,000 | |||||||||||||||||||||||||||
| (loss) from change in fair value of 2020/21 notes embedded derivative liability | |||||||||||||||||||||||||||||||
| gain from change in fair value of 2020/21 notes and 2020 notes embedded derivative liability | -8,578,000 | 247,000 | -176,000 | -100,000 | |||||||||||||||||||||||||||
| revenue | |||||||||||||||||||||||||||||||
| loss on exchange of debt | |||||||||||||||||||||||||||||||
| gain from change in fair value of 2020 notes embedded derivative | 148,000 |
We provide you with 20 years income statements for Gevo stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Gevo stock. Explore the full financial landscape of Gevo stock with our expertly curated income statements.
The information provided in this report about Gevo stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.